Profilo
Robert Case is currently the President at FasTraq, Inc. He previously worked as the Chief Executive Officer at Quantech Ltd.
Posizioni attive di Robert Case
| Società | Posizione | Inizio |
|---|---|---|
FasTraq, Inc.
 FasTraq, Inc. Medical SpecialtiesHealth Technology FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV. | Presidente | - |
Precedenti posizioni note di Robert Case
| Società | Posizione | Fine |
|---|---|---|
Quantech Ltd.
 Quantech Ltd. Medical SpecialtiesHealth Technology Quantech Ltd. engages in system design to increases the productivity, speed and cost effectiveness of the hospital emergency department through 'FasTraQ' a patient treatment information platform. The FasTraQ consists of an instrument that sits on the top of a counter and reads PrePaQ disposable test cartridges developed by the company. Its technology creates surface plasmon resonance in a controlled environment which enables the FasTraQ to detect and transmit information concerning the presence and quantity of certain native and foreign molecules in blood, urine which associated with specific diseases | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
FasTraq, Inc.
FasTraq, Inc. Medical SpecialtiesHealth Technology FasTraq, Inc. provides blood diagnosis solutions. The company's product includes FasTraQ ER-CPC workstation. It was founded in 2002 and is headquartered in Henderson, NV. | Health Technology |
Quantech Ltd.
Quantech Ltd. Medical SpecialtiesHealth Technology Quantech Ltd. engages in system design to increases the productivity, speed and cost effectiveness of the hospital emergency department through 'FasTraQ' a patient treatment information platform. The FasTraQ consists of an instrument that sits on the top of a counter and reads PrePaQ disposable test cartridges developed by the company. Its technology creates surface plasmon resonance in a controlled environment which enables the FasTraQ to detect and transmit information concerning the presence and quantity of certain native and foreign molecules in blood, urine which associated with specific diseases | Health Technology |
- Borsa valori
- Insiders
- Robert Case
